Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Wan

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Nuclear Medicine Communications|October 22, 2021
Renal protection during 177lutetium DOTATATE molecular radiotherapy in children: a proposal for safe amino acid infusional volume during peptide receptor radionuclide therapyCatherine A Taylor, Ananth Shankar, Mark N Gaze, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 24, 2025
Molecular radiotherapy for adult type metastatic neuroendocrine tumours in childrenConnie Peet, Caroline Elmaraghi, Tarek Abdel-Aziz, et al.
British Journal of Haematology|January 20, 2026
Clinical features and treatment outcomes of POEMS-associated Castleman diseaseGrace Lau, Victor Jia Wei Zhang, Zara Markovic-Obiago, et al.
NPJ Primary Care Respiratory Medicine|February 10, 2019
Comparison of adverse events associated with different spacers used with non-extrafine beclometasone dipropionate for asthmaSimon Wan Yau Ming, John Haughney, Dermot Ryan, et al.
Journal of Personalized Medicine|October 21, 2020
Personalisation of Molecular Radiotherapy through Optimisation of TheragnosticsLauraMay Davis, April-Louise Smith, Matthew D Aldridge, et al.
Insights Into Imaging|January 16, 2026
The role of multimodality imaging in selection, response assessment, and follow-up of patients receiving <sup>177</sup>Lutetium-PSMA-therapyAditi Ranjan, Minal Padden-Modi, Hoda Abdel-Aty, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 12, 2024
Improving head and neck sarcoma care: The impact of a specialized multidisciplinary team approach on diagnosis and patient outcomesDimitris Tatsis, Deepti Sinha, Franel Le Grange, et al.
Clinical Nuclear Medicine|September 9, 2016
Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in LymphomaAsim Afaq, Francesco Fraioli, Harbir Sidhu, et al.
Nature Reviews. Urology|November 10, 2025
Emerging evidence for sequencing and combining PSMA-based therapies in prostate cancerSola Adeleke, Joao R Galante, Yishen Wang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 10, 2019
Synergistic application of pulmonary <sup>18</sup>F-FDG PET/HRCT and computer-based CT analysis with conventional severity measures to refine current risk stratification in idiopathic pulmonary fibrosis (IPF)Francesco Fraioli, Maria Lyasheva, Joanna C Porter, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Nuclear Medicine Communications|October 22, 2021
Renal protection during 177lutetium DOTATATE molecular radiotherapy in children: a proposal for safe amino acid infusional volume during peptide receptor radionuclide therapyCatherine A Taylor, Ananth Shankar, Mark N Gaze, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 24, 2025
Molecular radiotherapy for adult type metastatic neuroendocrine tumours in childrenConnie Peet, Caroline Elmaraghi, Tarek Abdel-Aziz, et al.
British Journal of Haematology|January 20, 2026
Clinical features and treatment outcomes of POEMS-associated Castleman diseaseGrace Lau, Victor Jia Wei Zhang, Zara Markovic-Obiago, et al.
NPJ Primary Care Respiratory Medicine|February 10, 2019
Comparison of adverse events associated with different spacers used with non-extrafine beclometasone dipropionate for asthmaSimon Wan Yau Ming, John Haughney, Dermot Ryan, et al.
Journal of Personalized Medicine|October 21, 2020
Personalisation of Molecular Radiotherapy through Optimisation of TheragnosticsLauraMay Davis, April-Louise Smith, Matthew D Aldridge, et al.
Insights Into Imaging|January 16, 2026
The role of multimodality imaging in selection, response assessment, and follow-up of patients receiving <sup>177</sup>Lutetium-PSMA-therapyAditi Ranjan, Minal Padden-Modi, Hoda Abdel-Aty, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 12, 2024
Improving head and neck sarcoma care: The impact of a specialized multidisciplinary team approach on diagnosis and patient outcomesDimitris Tatsis, Deepti Sinha, Franel Le Grange, et al.
Clinical Nuclear Medicine|September 9, 2016
Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in LymphomaAsim Afaq, Francesco Fraioli, Harbir Sidhu, et al.
Nature Reviews. Urology|November 10, 2025
Emerging evidence for sequencing and combining PSMA-based therapies in prostate cancerSola Adeleke, Joao R Galante, Yishen Wang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 10, 2019
Synergistic application of pulmonary <sup>18</sup>F-FDG PET/HRCT and computer-based CT analysis with conventional severity measures to refine current risk stratification in idiopathic pulmonary fibrosis (IPF)Francesco Fraioli, Maria Lyasheva, Joanna C Porter, et al.
Pageof 8